The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...